982 related articles for article (PubMed ID: 19712768)
1. Efficient protective immunity against Trypanosoma cruzi infection after nasal vaccination with recombinant Sendai virus vector expressing amastigote surface protein-2.
Duan X; Yonemitsu Y; Chou B; Yoshida K; Tanaka S; Hasegawa M; Tetsutani K; Ishida H; Himeno K; Hisaeda H
Vaccine; 2009 Oct; 27(44):6154-9. PubMed ID: 19712768
[TBL] [Abstract][Full Text] [Related]
2. Genetic immunization based on the ubiquitin-fusion degradation pathway against Trypanosoma cruzi.
Chou B; Hiromatsu K; Hisaeda H; Duan X; Imai T; Murata S; Tanaka K; Himeno K
Biochem Biophys Res Commun; 2010 Feb; 392(3):277-82. PubMed ID: 20059980
[TBL] [Abstract][Full Text] [Related]
3. Strain-specific protective immunity following vaccination against experimental Trypanosoma cruzi infection.
Haolla FA; Claser C; de Alencar BC; Tzelepis F; de Vasconcelos JR; de Oliveira G; Silvério JC; Machado AV; Lannes-Vieira J; Bruna-Romero O; Gazzinelli RT; dos Santos RR; Soares MB; Rodrigues MM
Vaccine; 2009 Sep; 27(41):5644-53. PubMed ID: 19635607
[TBL] [Abstract][Full Text] [Related]
4. Trypanosoma cruzi: protective response of vaccinated mice is mediated by CD8+ cells, prevents signs of polyclonal T lymphocyte activation, and allows restoration of a resting immune state after challenge.
Paiva CN; Castelo-Branco MT; Lannes-Vieira J; Gattass CR
Exp Parasitol; 1999 Jan; 91(1):7-19. PubMed ID: 9920038
[TBL] [Abstract][Full Text] [Related]
5. Identification of Trypanosoma cruzi trans-sialidase family members as targets of protective CD8+ TC1 responses.
Wizel B; Nunes M; Tarleton RL
J Immunol; 1997 Dec; 159(12):6120-30. PubMed ID: 9550413
[TBL] [Abstract][Full Text] [Related]
6. Protective immunity against trypanosoma cruzi infection in a highly susceptible mouse strain after vaccination with genes encoding the amastigote surface protein-2 and trans-sialidase.
Vasconcelos JR; Hiyane MI; Marinho CR; Claser C; Machado AM; Gazzinelli RT; Bruña-Romero O; Alvarez JM; Boscardin SB; Rodrigues MM
Hum Gene Ther; 2004 Sep; 15(9):878-86. PubMed ID: 15353042
[TBL] [Abstract][Full Text] [Related]
7. Immunization with an engineered mutant trans-sialidase highly protects mice from experimental Trypanosoma cruzi infection: a vaccine candidate.
Fontanella GH; De Vusser K; Laroy W; Daurelio L; Nocito AL; Revelli S; Contreras R
Vaccine; 2008 May; 26(19):2322-34. PubMed ID: 18403070
[TBL] [Abstract][Full Text] [Related]
8. Effect of a combination DNA vaccine for the prevention and therapy of Trypanosoma cruzi infection in mice: role of CD4+ and CD8+ T cells.
Limon-Flores AY; Cervera-Cetina R; Tzec-Arjona JL; Ek-Macias L; Sánchez-Burgos G; Ramirez-Sierra MJ; Cruz-Chan JV; VanWynsberghe NR; Dumonteil E
Vaccine; 2010 Oct; 28(46):7414-9. PubMed ID: 20850536
[TBL] [Abstract][Full Text] [Related]
9. Vaccination using recombinants influenza and adenoviruses encoding amastigote surface protein-2 are highly effective on protection against Trypanosoma cruzi infection.
Barbosa RP; Filho BG; Dos Santos LI; Junior PA; Marques PE; Pereira RV; Cara DC; Bruña-Romero O; Rodrigues MM; Gazzinelli RT; Machado AV
PLoS One; 2013; 8(4):e61795. PubMed ID: 23637908
[TBL] [Abstract][Full Text] [Related]
10. Trypanosoma cruzi infection from the view of CD8+ T cell immunity--an infection model for developing T cell vaccine.
Miyahira Y
Parasitol Int; 2008 Mar; 57(1):38-48. PubMed ID: 17728174
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of a trans-sialidase-ISCOMATRIX subunit vaccine candidate to protect against experimental Chagas disease.
Bontempi IA; Vicco MH; Cabrera G; Villar SR; González FB; Roggero EA; Ameloot P; Callewaert N; Pérez AR; Marcipar IS
Vaccine; 2015 Mar; 33(10):1274-83. PubMed ID: 25625671
[TBL] [Abstract][Full Text] [Related]
12. Trypanosoma cruzi: roles for perforin-dependent and perforin-independent immune mechanisms in acute resistance.
Nickell SP; Sharma D
Exp Parasitol; 2000 Apr; 94(4):207-16. PubMed ID: 10831388
[TBL] [Abstract][Full Text] [Related]
13. Generation, specificity, and function of CD8+ T cells in Trypanosoma cruzi infection.
Martin D; Tarleton R
Immunol Rev; 2004 Oct; 201():304-17. PubMed ID: 15361249
[TBL] [Abstract][Full Text] [Related]
14. Perforin and gamma interferon expression are required for CD4+ and CD8+ T-cell-dependent protective immunity against a human parasite, Trypanosoma cruzi, elicited by heterologous plasmid DNA prime-recombinant adenovirus 5 boost vaccination.
de Alencar BC; Persechini PM; Haolla FA; de Oliveira G; Silverio JC; Lannes-Vieira J; Machado AV; Gazzinelli RT; Bruna-Romero O; Rodrigues MM
Infect Immun; 2009 Oct; 77(10):4383-95. PubMed ID: 19651871
[TBL] [Abstract][Full Text] [Related]
15. CD8+-T-cell-dependent control of Trypanosoma cruzi infection in a highly susceptible mouse strain after immunization with recombinant proteins based on amastigote surface protein 2.
Araújo AF; de Alencar BC; Vasconcelos JR; Hiyane MI; Marinho CR; Penido ML; Boscardin SB; Hoft DF; Gazzinelli RT; Rodrigues MM
Infect Immun; 2005 Sep; 73(9):6017-25. PubMed ID: 16113322
[TBL] [Abstract][Full Text] [Related]
16. Trypanosoma cruzi: protective immunity in mice immunized with paraflagellar rod proteins is associated with a T-helper type 1 response.
Miller MJ; Wrightsman RA; Manning JE
Exp Parasitol; 1996 Nov; 84(2):156-67. PubMed ID: 8932765
[TBL] [Abstract][Full Text] [Related]
17. Critical contribution of immunoproteasomes in the induction of protective immunity against Trypanosoma cruzi in mice vaccinated with a plasmid encoding a CTL epitope fused to green fluorescence protein.
Chou B; Hisaeda H; Shen J; Duan X; Imai T; Tu L; Murata S; Tanaka K; Himeno K
Microbes Infect; 2008 Mar; 10(3):241-50. PubMed ID: 18321749
[TBL] [Abstract][Full Text] [Related]
18. Depletion of CD8+ T cells increases susceptibility and reverses vaccine-induced immunity in mice infected with Trypanosoma cruzi.
Tarleton RL
J Immunol; 1990 Jan; 144(2):717-24. PubMed ID: 2104903
[TBL] [Abstract][Full Text] [Related]
19. Acute Trypanosoma cruzi infection: IL-12, IL-18, TNF, sTNFR and NO in T. rangeli-vaccinated mice.
Basso B; Cervetta L; Moretti E; Carlier Y; Truyens C
Vaccine; 2004 May; 22(15-16):1868-72. PubMed ID: 15121297
[TBL] [Abstract][Full Text] [Related]
20. In vivo administration of recombinant IFN-gamma induces macrophage activation, and prevents acute disease, immune suppression, and death in experimental Trypanosoma cruzi infections.
Reed SG
J Immunol; 1988 Jun; 140(12):4342-7. PubMed ID: 3131431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
